Table 2.
Variable | Non-CKD N=2,396 |
Any CKD N=212 |
P value | CKD 1–2 N=165 |
CKD 3–5 N=47 |
P value |
---|---|---|---|---|---|---|
CAC ≥100 Agatston units, N (%) | 200 (8.4) | 46 (21.8) | <0.001 | 27 (16.6) | 18 (40.0) | 0.0007 |
LV mass/BSA, g/m2, median (IQR) | 79.6 (69.8, 92.1) | 91.9 (78.5, 110.9) | <0.001 | 93.2 (81.1, 112.1) | 83.6 (70.9, 101.9) | 0.02 |
LVH, N (%) | 225 (9.4) | 69 (32.6) | <0.001 | 57 (34.6) | 12.(26.7) | 0.32 |
Aortic PWV, m/s, median (IQR) | 4.2 (3.3, 5.6) | 5.4 (4.0, 7.0) | <0.001 | 5.3 (3.9, 6.7) | 6.6 (4.4, 8.6) | 0.03 |
Note: Includes 2,608 participants who underwent testing for intermediate CV outcomes
BSA, body surface area; CAC, coronary artery calcification; CKD, chronic kidney disease; IQR, interquartile range; LV, left ventricular; LVH, left ventricular hypertrophy; PWV, pulse wave velocity.